Integrative Cancer Science and Therapeutics

An Open Access, Peer Reviewed Journal
NLM ID : 101660140
Impact-Factor: 1.981*
Online ISSN: 2056-4546

Volume 08, Issue 06


The effect of low doses of verapamil on the course of Kaposi's sarcoma

Gridina Nina Yakivna

Case Report-Integrative Cancer Science and Therapeutics (ICST)

Dec 10, 2021


Editorial comments to the articles published in Volume 8

Hiroshi Miyamoto

Case Report-Integrative Cancer Science and Therapeutics (ICST)

Dec 26, 2021


About Journal



Integrative Cancer Science and Therapeutics is an open access, peer-reviewed online journal interested in attracting high-quality original research and reviews that present or highlight significant advances in all areas of cancer and related biomedical science. The Journal is concerned with basic, translational and clinical research, across different disciplines and areas, enhancing insight in understanding, prevention, diagnosis and treatment of cancer. The journal also prioritizes clinical trials evaluating new treatments, accompanied by research on pharmacology and molecular alterations or biomarkers that predict response or resistance to treatment.

Integrative Cancer Science and Therapeutics welcomes submission of papers both at the molecular, subcellular, cellular, organ, and organism level, and of clinical proof-of-concept and translational studies. Topics of interest include, but are not limited to: novel basic cancer research discoveries, cell and tumor biology, animal models, metastasis, cancer antigens and the immune response to them, cellular signalling and molecular biology, epidemiology, genetic and molecular profiling of cancer and molecular targets, cancer stem cells, cancer-associated pathways (including cell-cycle regulation; cell death; chromatin regulation; DNA damage and repair; gene and RNA regulation; genomics; oncogenes and tumor suppressors; and signal transduction), molecular virology and vaccine- and antibody-based cancer therapies, and other cancer-related research.

Integrative Cancer Science and Therapeutics provides an important forum for exchange of ideas, concepts and findings in any area of cancer and related biomedical science. The online appearance of Integrative Cancer Science and Therapeutics allows the immediate publication of accepted articles and the presentation of large amounts of data and supplemental information to ensure that new research is disseminated as efficiently and quickly as possible to the scientific community.

Manuscripts may be submitted as Original Articles, Rapid and Short Communications, Reviews, Mini-review, Case Reports, Opinion, Letters to the Editor and Editorials. Integrative Cancer Science and Therapeutics is proud of its fast Reviewing and Editorial Decision system. Manuscripts are normally evaluated by three members from an international panel of reviewers and, in most cases, we provide a first editorial decision within 21 days of receipt.

Integrative Cancer Science and Therapeutics welcomes direct submissions of manuscripts from authors. You can submit your manuscript to : submissions@oatext.com; alternatively to : editor.icst@oatext.com

*2019 Impact Factor is the ratio of the number of citations achieved in the year 2018 based on Google Search and Google Scholar Citations to the total number of articles published in the last two years i.e. in 2016 and 2017. Impact factor measures the quality of the Journal. If ‘X’ is the total number of articles published in 2016 and 2017, and ‘Y’ is the number of times these articles were cited in indexed journals during 2018 then, impact factor = Y/X.

Hiroshi Miyamoto


Hiroshi Miyamoto, MD, PhD, completed his medical school and urology residency training followed by clinical urology practice and translational research in genitourinary cancers in Japan. In 1996, he moved to the United States to conduct postdoctoral research at University of Wisconsin - Madison and University of Rochester. He then completed anatomic pathology residency training at University of Rochester Medical Center and clinical fellowship in urologic pathology at The Johns Hopkins Hospital. Since 2009, he has been the faculty as a surgical pathologist as well as an independent investigator at University of Rochester School of Medicine and Dentistry (2009-2013 & 2016-present) and Johns Hopkins University School of Medicine (2013-2016). He is currently the Professor of Pathology & Laboratory Medicine, Urology, and Oncology, and also serves as the Director of Genitourinary Pathology at University of Rochester Medical Center.

Dr. Miyamoto’s primary research interest includes molecular biology of steroid hormone receptors in genitourinary tumors. Specifically, he has been investigating the role of androgen receptor signals in the development and progression of urothelial cancer as well as resistance to conventional therapy for bladder cancer. Epidemiological and clinical data indicate that men have a substantially higher risk of bladder cancer, whereas women tend to present with more aggressive tumors. The underlying mechanisms of how androgens regulate urothelial tumorigenesis and tumor outgrowth will offer explanations for these gender-specific differences in cancer incidence and aggressiveness. He has also assessed the effects of new classes of androgen receptor antagonists on prostate cancer progression and has characterized novel androgen receptor co-regulators in prostate cancer cells. He has published more than 200 peer-reviewed articles and 17 book chapters.

Hiroshi Miyamoto


Hiroshi Miyamoto, MD, PhD, completed his medical school and urology residency training followed by clinical urology practice and translational research in genitourinary cancers in Japan. In 1996, he moved to the United States to conduct postdoctoral research at University of Wisconsin - Madison and University of Rochester. He then completed anatomic pathology residency training at University of Rochester Medical Center and clinical fellowship in urologic pathology at The Johns Hopkins Hospital. Since 2009, he has been the faculty as a surgical pathologist as well as an independent investigator at University of Rochester School of Medicine and Dentistry (2009-2013 & 2016-present) and Johns Hopkins University School of Medicine (2013-2016). He is currently the Director of Genitourinary Pathology at University of Rochester Medical Center.

Dr. Miyamoto’s primary research interest includes molecular biology of steroid hormone receptors in genitourinary tumors. Specifically, he has been investigating the role of androgen receptor signals in the development and progression of urothelial cancer. Epidemiological and clinical data indicate that men have a substantially higher risk of bladder cancer, whereas women tend to present with more aggressive tumors. The underlying mechanisms of how androgens regulate urothelial tumorigenesis and tumor outgrowth will offer explanations for these gender-specific differences in cancer incidence and aggressiveness. He has also assessed the effects of new classes of androgen receptor antagonists on prostate cancer progression and has characterized novel androgen receptor co-regulators in prostate cancer cells. He has published more than 160 peer-reviewed articles and 17 book chapters.

Editor-in-Chief


Hiroshi Miyamoto

University of Rochester Medical Center, USA

Read more

Editorial Board


Yu-Jui Yvonne Wan

Professor and Vice Chair of Research
Department of Medical Pathology & Laboratory Medicine
University of California, Davis Medical Center

Glen J. Weiss

Clinical Associate Professor
Translational Genomics Research Institute (TGen)
Clinical Assistant Professor of Medicine
The University of Arizona College of Medicine-Phoenix
Director of Clinical Research
Cancer Treatment Centers of America

Ben Warner

Clinical Associate Professor
Department of General Practice and Dental Public Health
The University of Texas


Rajagopal Ramesh

Professor of Pathology
Director, Experimental Therapeutics and Translational Cancer Medicine
University of Oklahoma Health Sciences Center

Donald J. Alcendor

Assistant Professor of Cancer Biology
Meharry Medical College
Adjunct Assistant Professor of Cancer Biology
Vanderbilt School of Medicine

Toru Ouchi

Professor of Oncology
Department of Cancer Genetics
Roswell Park Cancer Institute


Arun K. Rishi

Professor
Department of Oncology and Internal Medicine
Karmanos Cancer Institute
Wayne State University

Moshe Talpaz

Associate Chief
Division of Hematology/Oncology
University of Michigan Health System

Ming Zhang

Associate Professor
Northwestern University Feinberg School of Medicine
Department of Biochemistry
Robert H. Lurie Comprehensive Cancer Center, and Center for Genetic Medicine


Vicente Notario

Professor
Department of Radiation Medicine
Leader, Molecular Oncology Program
Lombardi Comprehensive Cancer Center
Georgetown University Medical Center

Charlie Ma

Professor Vice Chairman, Department of Radiation Oncology
Director, Radiation Physics
Fox Chase Cancer Center

Pranela Rameshwar

Professor
Medicine-Hematology/Oncology
Rutgers-New Jersey Medical School


Awad Shamma

Division of Oncology and Molecular Biology,
Cancer and Stem Cell Research Program
Kanazawa University Cancer Research Institute

Rebecca B. Riggins

Assistant Professor
Breast Cancer Program
Lombardi Comprehensive Cancer Center
Georgetown University Medical Center

Lucio Miele

Professor of Medicine and Director for Inter-Institutional Programs
LSU Stanley Scott Cancer Center and Louisiana Cancer Research Consortium


Leonidas G. Koniaris

Professor of Surgery (Surgical Oncology)
Vice Chair of Research
IU Health University Hospital, Surgery OP Clinic
Indiana University

Alfio Ferlito

Director of the Department of Surgical Sciences
Professor and Chairman of the ENT Clinic
University of Udine School of Medicine

Masakazu Toi

Professor
Breast Surgery
Kyoto University


Kazuya Fukuoka

Associate Professor Department of Medical Oncology, Sakai Hospital, Kinki University Faculty of Medicine, Japan

Makoto Takahama

Director and Chairman Department of General Thoracic Surgery Osaka City General Hospital, Japan

Jitsuo Usuda

Professor, Department of Thoracic Surgery Nippon Medical School, Japan


Yoshitane Tsukamoto

Associate Professor
Department of Surgical Pathology
Hyogo College of Medicine, Japan

Yasuhiro Koh

Assistant Professor
Third Department of Internal Medicine
Wakayama Medical University, Japan

Akito Hata

Deputy Head Physician
Division of Integrated Oncology
Institute of Biomedical Research and Innovation, Japan


Kazushi Inoue

Associate Professor
Pathology - Tumor Biology
Wake Forest University School of Medicine
USA

Michael J Gonzalez

Professor
University of Puerto Rico Medical Sciences Campus
School of Public Health
Department of Human Development
Puerto Rico

Canan Hascicek

Associate Professor
Department of Pharmaceutical Technology
Ankara University
Turkey


Yang Xueqin

Cancer Center, Institute of Surgery Research and Daping Hospital
Third Military Medical University
China

Dr. Tanja Khosrawipour

Department for General and special visceral surgery
Center for Peritoneal Carcinomatosis
University Hospital of the Ruhr-University Bochum
Germany

Antonio Herreros Martínez

Associate Professor
Department of Basic Clinical Practice
Faculty of Medicine
Universitat de Barcelona
Spain


Ying-Yu Cui

Associte Professor
Department of Regenerative Medicine
Tongji University School of Medicine
China

Hiroshi Miyamoto

Director
Genitourinary Section
University of Rochester Medical Center
USA

Damir Nizamutdinov

Assistant Professor
Department of Surgery
Texas A&M Health Science Center
USA


Michael J. McKay

Professor
Radiation Oncology
Sydney University
Australia

Antonio Vaz de Macedo

Head of the Bone Marrow Transplant Unit
Hospital das Clínicas
Federal University of Minas Gerais
Brazil

Canzhong Lu

Professor
Chinese Academy of Sciences
China


Jianping Yong

Associate Professor
Chinese Academy of Sciences
P. R. China

In Press


Will be update soon.

Current Issue

Volume 9, Issue 1


APE1/Ref-1 with reducing activity induces mesenchymal-to-epithelial transition in TNF-α-stimulated breast cancer cells

Sunga Choi Ki Mo Kim Euna Choi

Research Article-Integrative Cancer Science and Therapeutics (ICST)

undefined


Intensity modulated radiotherapy and targeted therapy for late nonregional para-aortic lymph node metastasis from HER2 positive breast carcinoma

Lena Marinova Vaska Vassileva Viktor Petrov Iliya Gabrovski

Case Report-Integrative Cancer Science and Therapeutics (ICST)

undefined


Archive


Volume 9

APE1/Ref-1 with reducing activity induces mesenchymal-to-epithelial transition in TNF-α-stimulated breast cancer cells

Sunga Choi Ki Mo Kim Euna Choi

Research Article-Integrative Cancer Science and Therapeutics (ICST)

undefined


Intensity modulated radiotherapy and targeted therapy for late nonregional para-aortic lymph node metastasis from HER2 positive breast carcinoma

Lena Marinova Vaska Vassileva Viktor Petrov Iliya Gabrovski

Case Report-Integrative Cancer Science and Therapeutics (ICST)

undefined


Volume 8

The effect of low doses of verapamil on the course of Kaposi's sarcoma

Gridina Nina Yakivna

Case Report-Integrative Cancer Science and Therapeutics (ICST)

Dec 10, 2021


Editorial comments to the articles published in Volume 8

Hiroshi Miyamoto

Case Report-Integrative Cancer Science and Therapeutics (ICST)

Dec 26, 2021


A case report of giant hepatic hemangioma spontaneous regression in adult, non-cirrhotic patient and literature review

Scarinci Andrea De Peppo Valerio Grazi Gian Luca

Case Report-Integrative Cancer Science and Therapeutics (ICST)

Nov 23, 2021


Ataxia-telangiectasia

Adel Ekladious

Mini-Review-Integrative Cancer Science and Therapeutics (ICST)

June 13, 2021


A case of chylothorax due to diffuse large B-Cell lymphoma

Fusun Sahin

Case Report-Integrative Cancer Science and Therapeutics (ICST)

June 18, 2021


Molecular characterization of prevalence, serotypes, virulence factors, and antibiotic resistance of Streptococcus agalactiae in a maternity hospital, Iran

Shokouh Sadat Haji Seyed Aboutorabi Zohreh Rasooli Hamideh Pakniat Fahimeh Baloo

Research Article-Integrative Cancer Science and Therapeutics (ICST)

April 17, 2021


Exosomes as therapy for cancer

Rocío Retamales-Ortega María Lorena Oróstica

Mini Review-Integrative Cancer Science and Therapeutics (ICST)

April 26, 2021


Putative oncogenic viruses: Some data on Brazilian subjects

Bernardo G Tenorio Isadora S Bretas Joao PRA Bernardes Munnah NJ Mansour Sarah MS Napoleao Sheyla AS Rocha Thatiane L Sampaio Elisiario CV Leitao Joaquim X Silva Marcus VS Coimbra Edson JM Bello Elida CGM Kanzaki I. Kanzaki

Review Article-Integrative Cancer Science and Therapeutics (ICST)

May 31, 2021


Phytotherapy and oncology. A short review

A Sannia

Mini Review-Integrative Cancer Science and Therapeutics (ICST)

Feb 26, 2021


Compound cantharis revers chemotherapy resistance of TNBC via miR-520d/Beclin-1 signal axis

Hongchang Li Huan Liu Yafeng Chen Jie Li Weiyan Liu Ke Xu Dianxu Feng Xia Sheng

Research Article-Integrative Cancer Science and Therapeutics (ICST)

March 26, 2021


Evinacumab - a new drug in the treatment of homozygous familial hypercholesterolaemia

Stanisław Surma Monika Romańczyk Krzysztof J. Filipiak

Mini Review-Integrative Cancer Science and Therapeutics (ICST)

April 09, 2021


Exploiting mechanism-informed phenotypic screening for development of next-generation antimitotic phytochemicals

Namrta Choudhry Thaddeus David Allen Vidhula Ahire Jing Zhang Dun Yang

Commentary-Integrative Cancer Science and Therapeutics (ICST)

Jan 06, 2021


Prospects for colorectal cancer prevention targeting intestinal microbiome

Tadashi Ohara, MD, PhD

Mini Review-Integrative Cancer Science and Therapeutics (ICST)

Jan 29, 2021


Sclerosing Pneumocytoma: A Carcinoma Mimicker

Licheng Song Peng Yan Guoxin Mo

Case Report-Integrative Cancer Science and Therapeutics (ICST)

Feb 23, 2021


Volume 7

Melatonin at the crossroads: Commentary on COVID and cognition

Constantine Kaniklidis

Commentary-Integrative Cancer Science and Therapeutics (ICST)

Nov 23, 2020


Establishment of an orthotopic syngeneic rat model of hepatocellular carcinoma and its validation with microPET-CT imaging

Geetanjali Singh Kiran Bendale Sarang Talwelkar Shital Pawade Poonam Gera Asawari Patil Preeti Chavan Suresh Subramanian Pradip Chaudhari

Research Article-Integrative Cancer Science and Therapeutics (ICST)

Dec 14, 2020


Phospholipase A2 as a novel therapeutic target in lung cancer

Fang-Yuan Zhang Run-Ze Li Jia-Xin Li Xing-Xing Fan Chun- Xie Liang Liu Xiao-Jun Yao Elaine Lai-Han Leung

Review Article-Integrative Cancer Science and Therapeutics (ICST)

Dec 24, 2020


Regorafenib or Cabozantinib in second or subsequent lines after Sorafenib in advanced hepatocellular carcinoma. Which way to chose?

Jacopo Giuliani Francesco Fiorica Andrea Bonetti

Research Article-Integrative Cancer Science and Therapeutics (ICST)

Sep 27, 2020


First branchial arch anomaly: A rare lesion not to be underestimated

Stefano Dallari Federica Maroni Alessandra Filosa Massimo Giuliano Bonetti

Case Report-Integrative Cancer Science and Therapeutics (ICST)

Oct 03, 2020


Practical working guideline and phantom simulation for radiotherapy during the outbreak of COVID-19 in the Republic of Korea

Eun Kyung Paik Won Il Jang Chang-Youn Park Eunji Kim Sang-Hyoun Choi Soon-Sung Lee

Letter to the editor-Integrative Cancer Science and Therapeutics (ICST)

Oct 18, 2020


Targeting the phosphatidylinositol 3-kinase signaling pathway in acute myeloid leukemia

Ota Fuchs

Review Article-Integrative Cancer Science and Therapeutics (ICST)

July 28, 2020


Lipoxin A4 a novel therapeutic agent for the treatment of breast cancer metastases

Browne E Chen H Vencken S Condron CM

Research Article-Integrative Cancer Science and Therapeutics (ICST)

May 13, 2020


Ovarian tumor diagnosed during pregnancy & their management

Harsha Khullar Geeta Mediratta Sharmistha Garg

Case Series-Integrative Cancer Science and Therapeutics (ICST)

June 19, 2020


A case report of decongestive therapy for treatment of lymphedema in a patient with breast cancer

Enkeleda Sinaj Fatjona Kamberi

Case Report-Integrative Cancer Science and Therapeutics (ICST)

June 23, 2020


Typical versus atypical antipsychotics: Genotoxicity and cytostaticity testing

Evangelos G. Katsioulis Maria Argyraki Maria T. Ekonomopoulou Constantine Mourelatos Zafiroula Iakovidou-Kritsi Dionysios Mourelatos

Research Article-Integrative Cancer Science and Therapeutics (ICST)

June 26, 2020


Kinetics of immune reconstitution and immune complications after cell and organ transplantation

Usha Kellampalli Hesham Mohei Irina Vlasova-St. Louis

Review Article-Integrative Cancer Science and Therapeutics (ICST)

June 29, 2020


Patient-derived cell model for the study of prostate cancer biology and therapeutic development

Johng S. Rhim

Commentary-Integrative Cancer Science and Therapeutics (ICST)

February 25, 2020


Understanding cancer breakpoint determinants with omics data

Kseniia Cheloshkina Maria Poptsova

Commentary-Integrative Cancer Science and Therapeutics (ICST)

March 23, 2020


Immune-checkpoint inhibitor anti-PD1 aggravates colitis-associated colorectal cancer without enhancing intestinal inflammation

Maxime Collard Nathalie Guedj Julien Tourneur-Marsille Miguel Albuquerque Léon Maggiori Pascal Hammel Xavier Treton Yves Panis Eric Ogier-Denis

Research Article-Integrative Cancer Science and Therapeutics (ICST)

April 10, 2020


Non-hereditary risk factors associated with pancreatic cancer: a focus on obesity and diabetes

Céline Tiffon

Editorial-Integrative Cancer Science and Therapeutics (ICST)

April 17, 2020


The effect of CIK-cell therapy in combination with anticancer agents in patients with inoperable pancreato-biliary cancer

Lee Jiyoung Park Jinhee Chae Jinsung Jung Gyouchul Yeom Changhwan

Research Article-Integrative Cancer Science and Therapeutics (ICST)

April 29, 2020


Ophthalmologic manifestations in Acute Leukemia

Franco Benvenuto Mariana Sgroi Soledad Guillen Guillermo Chantada Adriana Fandiño

Research Article-Integrative Cancer Science and Therapeutics (ICST)

January 23, 2020


TACE in colorectal liver metastases – different outcomes in right-sided and left-sided primary tumour location

S. Seidl P. Bischoff A. Schaefer M. Esser V. Janzen A. Kovács

Research Article-Integrative Cancer Science and Therapeutics (ICST)

January 30, 2020


What silence has to offer the clinical encounter

Patricia Lynn Dobkin

Commentary-Integrative Cancer Science and Therapeutics (ICST)

February 10, 2020


Hydroxyindole O-methyltransferase controls cancer growth and metastasis

Kenneth K Wu

Commentary-Integrative Cancer Science and Therapeutics (ICST)

February 17, 2020


A better understanding of cancer metabolism for a more efficient immunotherapy

Douae Bensaid Kawtar Raghay Christophe Blanquart

Letter to Editor-Integrative Cancer Science and Therapeutics (ICST)

February 24, 2020


Volume 6

Decoding artificial intelligence and machine learning concepts for cancer research application

Renaud Seigneuric Isabelle Bichindaritz

Review Article-Integrative Cancer Science and Therapeutics (ICST)

September 17, 2019


Non small cell lung cancer with targetable driver alterations: Imaging perspective

Eric W. Zhang Subba R. Digumarthy

Review Article-Integrative Cancer Science and Therapeutics (ICST)

November 24, 2019


Clinically unexpected lymph node: An old enemy to remember in the cancer diagnosis and treatment

Imdat Eroglu Burak Yasin Aktas Olcay Kurtulan Deniz Can Güven Sercan Aksoy

Case Report-Integrative Cancer Science and Therapeutics (ICST)

November 27, 2019


Ginseng extract and its constituents alleviate cisplatin toxicity and reverse cisplatin resistance

Jian Cai Huihong Huang

Review Article-Integrative Cancer Science and Therapeutics (ICST)

December 13, 2019


Impedimetric label-free detection of salivary EGFR on screen printed electrode

Imad Abrao Nemeir Joseph Saab Walid Hleihel Abdelhamid Errachid Nadia Zine

Short Communication-Integrative Cancer Science and Therapeutics (ICST)

September 24, 2019


Myelodysplastic syndrome (MDS), diagnosis, prognosis and the best available treatment

Jalil Ur Rehman Al Johani NI Mahnoor Jalil

Mini Review-Integrative Cancer Science and Therapeutics (ICST)

October 03, 2019


Is the rate of frozen section discordance affected by subspecialty sign out? A quality improvement study

Joseph H. Blitman Brandon Buscaglia Christa L. Whitney-Miller David G. Hicks Aaron R. Huber

Research Article-Integrative Cancer Science and Therapeutics (ICST)

October 25, 2019


How to integrate medical oncology and palliative care?

Alexandru C. Grigorescu Teodorescu Laura Mihaela

Editorial-Integrative Cancer Science and Therapeutics (ICST)

October 26, 2019


Mutational Crosstalk between nuclear driver genes and mitochondrial DNA in gingivobuccal oral cancer

Arindam Palodhi Soumi Sarkar Arindam Maitra

Perspective-Integrative Cancer Science and Therapeutics (ICST)

October 29, 2019


Increasing the yield of the high-resolution anoscopy with endoscopic assistance: A Gastroenterologist’s Perspective

Harish Patel Hassan Tariq Jasbir Makker Rafeeq Ahmed Mariela Glandt Peter Bhandari Vamshidhar Vootla Chaitanya Chandrala Sridhar Chilimuri

Case Report-Integrative Cancer Science and Therapeutics (ICST)

July 08, 2019


Can human leukocyte antigen G be widely accepted as a biomarker in cancer clinical practice?

Kevin Yi-Xiao Yie Shang-Mian Yie

Commentary-Integrative Cancer Science and Therapeutics (ICST)

July 17, 2019


PD-1 Inhibitor-induced Gastroenterocolitis: A Mini Review

Phoenix D. Bell Aaron R. Huber

Mini Review-Integrative Cancer Science and Therapeutics (ICST)

August 14, 2019


Immunity or morphogenesis in cancer development and treatment

Shoutko AN

Review Article-Integrative Cancer Science and Therapeutics (ICST)

August 17, 2019


TET enzymes and key signalling pathways: Crosstalk in embryonic development and cancer

Karina Bezerra Salomão Gustavo Alencastro Veiga Cruzeiro Pablo Ferreira das Chagas Ricardo Bonfim-Silva María Sol Brassesco Luiz Gonzaga Tone

Review Article-Integrative Cancer Science and Therapeutics (ICST)

August 21, 2019


Endoscopic application of clipping, over-the-scope clip (OTSC) and stenting for a fistula and anastomotic leakage of upper gastro- intestinal tract

Hiroshi Makino Satoshi Nomura Hiroshi Maruyama Tadashi Yokoyama Atsushi Hirakata Yuta Kikuchi Masafumi Yoshioka Takuma Iwai Tsutomu Nomura Hiroshi Yoshida

Research Article-Integrative Cancer Science and Therapeutics (ICST)

May 30, 2019


Combined transurethral resection and laparoscopic paritial cystectomy for the treatment of bladder endometriosis: A case report

Xiaobo Huang Hubisihaletu Liang Gu Yonghua Wu Haiyun Ye Qingquan Xu

Case Report-Integrative Cancer Science and Therapeutics (ICST)

June 01, 2019


Editorial comments to the articles published in Issues 1-3 of Volume 6

Hiroshi Miyamoto

Editorial-Integrative Cancer Science and Therapeutics (ICST)

June 24, 2019


Impact of demographic, clinical and psychological variables of patients and caregivers on the perception of burden among the family caregivers of patients with cancer

Badii Amamou Soumaya Fathallah Dhekra Ammar Ahmed Mhalla Ferid Zaafrane Lotfi Gaha

Research Article-Integrative Cancer Science and Therapeutics (ICST)

March 19, 2019


Absolute quantification of stool-based colon cancer microRNAs by chip-based digital (d)PCR

Farid E Ahmed

Editorial-Integrative Cancer Science and Therapeutics (ICST)

April 01, 2019


Aquaporin 1 (AQP1) regulates plasma membrane bleb formation by facilitating bleb retraction phase in cancer cells

Godwin A. Ponuwei Phil R. Dash

Research Article-Integrative Cancer Science and Therapeutics (ICST)

April 18, 2019


Concordance between the WCRF recommendations and reduced global cardiovascular risk in a cohort of survived breast cancer patients

Simone Magro Francesco Sofi Gabriele Mascherini Giorgio Galanti Laura Stefani

Research Article-Integrative Cancer Science and Therapeutics (ICST)

April 27, 2019


Odontogenic Choriostoma in buccal mucosa associated with suspected Goldenhar Syndrome

Prashant M Battepati Priyanka Gupta Bhari Sharanesha Manjunatha Bheema Setty Manasali

Case Report-Integrative Cancer Science and Therapeutics (ICST)

April 28, 2019


GY II represses proliferation and metastasis and promotes apoptosis in laryngeal squamous cell carcinoma

Yunfei Bai Ru Wang Xiaobo Cui Lin Feng Qian Shi Hongzhi Ma Meng Lian Xixi Shen Yifan Yang Chen Tan Jugao Fang

Research Article-Integrative Cancer Science and Therapeutics (ICST)

December 26, 2018


Patents-4-Patients - The Cancer Moonshot gets EXTENDED!

Joseph E. Kovarik

Commentary-Integrative Cancer Science and Therapeutics (ICST)

January 14, 2019


“The host’s role in hepatocellular carcinoma development: A case of regression from probable malignancy to a benign lesion”

Divya M Chalikonda Brianna J Shinn Christopher Roth Hie-Won Hann

Case Report-Integrative Cancer Science and Therapeutics (ICST)

February 4, 2019


Phase transitions in tumor growth VII: The effect of periodic glucose pulses and privations in a cancer model

Pomuceno-Orduñez JP Silva E Martin RR Durán I Bizzarri M Cocho G Mansilla R Nieto-Villar JM

Research Article-Integrative Cancer Science and Therapeutics (ICST)

February 23, 2019


Trastuzumab emtansine is the standard second-line treatment following horizontal blockade in first line of advanced HER-2 positive breast cancer: A plant that has still to grow

Liliana Montella Salvatore Del Prete Pasquale Bove

Commentary-Integrative Cancer Science and Therapeutics (ICST)

February 26, 2019


Volume 5

Reduction in oral mucositis severity using a topical vasoconstrictor: A case report of three bone marrow transplant patients

Amanda Graul-Conroy Margo Hoover-Regan Kenneth B. DeSantes Paul M. Sondel Natalie S. Callander Walter L. Longo William E. Fahl

Case Report-Integrative Cancer Science and Therapeutics (ICST)

November 29, 2018


DPYSL3 is a mutifunctional modulator in claudin-low breast cancer

Ryoichi Matsunuma Matthew J. Ellis

Commentary-Integrative Cancer Science and Therapeutics (ICST)

December 14, 2018


A particular dubrheuil melanoma

Ouiame.EL Jouari Sara Elloudi Ghita Senhaji A Lahlou Mimi Zakia Douhi Hanane Baybay Mouna Rimani Fatima Zahra Mernissi

Commentary-Integrative Cancer Science and Therapeutics (ICST)

December 19, 2018


Mitochondrial Lon protease-unique structure and essential function in mammalian cells

Eva Kutejová

Editorial-Integrative Cancer Science and Therapeutics (ICST)

December 22, 2018


Absolute digital(d)PCR quantification of micro(mi)RNA molecules for the diagnostic screening of colon cancer in human stool: A methodological review

Farid E. Ahmed Nancy C. Ahmed Mostafa M. Gouda

Review Article-Integrative Cancer Science and Therapeutics (ICST)

December 18, 2018


The practical application of gene vectors in cancer therapy

Yong Kiel Sung Sung Wan Kim

Review Article-Integrative Cancer Science and Therapeutics (ICST)

September 26, 2018


Impact of a functional-based exercise program on fatigue, quality of life, and muscular endurance in cancer patients: A pilot study

Keauna Braun Megan Chelberg Elizabeth Hanke Samantha Lefaive Lauren Lenz Matthew S. Wiggins

Research Article-Integrative Cancer Science and Therapeutics (ICST)

September 28, 2018


Survival difference associated with controlled-release oxycodone analgesic therapy for oxaliplatin-induced peripheral neuropathy in advanced colorectal cancer patients

Makoto Nagashima Ayako Hiranuma Takashi Oshiro Yu Sato Tomoaki Kitahara Taiki Nabekura Yuki Moriyama Motoaki Arai Mika Ando Kengo Kadoya Ayami Sato Kentaro Kawamitsu Ryuichi Takagi Tasuku Urita Yutaka Yoshida Hiroshi Tanaka Shinichi Okazumi

Research Article-Integrative Cancer Science and Therapeutics (ICST)

October 01, 2018


Macrophages promote progression of lung cancer by regulating ubiquitin-specific peptidase 17 in cancer cells

Chih-Hao Lu Chao-Yang Lai Tsung-Hsien Chuang

Mini Review-Integrative Cancer Science and Therapeutics (ICST)

October 16, 2018


Breast cancer: Metronomic therapy focused on muscarinic acetylcholine receptors

María Elena Sales

Mini Review-Integrative Cancer Science and Therapeutics (ICST)

October 24, 2018


HeberFERON, a promising choice for the treatment of basal cell carcinoma

Iraldo Bello Rivero

Editorial-Integrative Cancer Science and Therapeutics (ICST)

October 30, 2018


Translocations involving ETS family proteins in human cancer

Elizabeth A. Fry Ali Mallakin Kazushi Inoue

Review Article-Integrative Cancer Science and Therapeutics (ICST)

July 20, 2018


Solubilization and penetration enhancement of water-soluble and amphiphilic phospholipid polymer aggregate for poorly soluble drugs

Tomohiro Konno Kazuhiko Ishihara

Mini-Review-Integrative Cancer Science and Therapeutics (ICST)

August 20, 2018


Controversy regarding the functional conservation of cereblon CUL4-type E3 ligase substrate receptor

Afua A Akuffo Aileen Y Alontaga Harshani R Lawrence Nicholas J. Lawrence Pearlie K Epling-Burnette

Commentary-Integrative Cancer Science and Therapeutics (ICST)

August 22, 2018


Erysipelas of the upper extremity: About 25 cases of breast cancer with loco regional therapy

Saadani CH Baybay H Zinoune S Douhi Z Mernissi FZ

Research Article-Integrative Cancer Science and Therapeutics (ICST)

August 23, 2018


Rationale for the design of a novel tool for immunotherapy based on an emulsion of glycosaminoglycan

Marco Ruggiero Stefania Pacini

Commentary-Integrative Cancer Science and Therapeutics (ICST)

August 27, 2018


Cancer care professionals should pay more attention to the sexual aspects of cancer in men with a non-mainstream sexual orientation

Woet L. Gianotten Haakon Aars

Review Article-Integrative Cancer Science and Therapeutics (ICST)

August 29, 2018


Persistent Risk for Hepatocellular carcinoma in patients on antiviral treatment: A Need for HBV cure

Joseph Yoo Grace Park Richard S. Hann Hie-Won Hann

Commentary-Integrative Cancer Science and Therapeutics (ICST)

May 28, 2018


Glucose starvation as cancer treatment: Thermodynamic point of view

Durán I Pomuceno-Orduñez JP Martín RR Silva E Montero S Mansilla R Cocho G Nieto-Villar JM

Research Article-Integrative Cancer Science and Therapeutics (ICST)

May 31, 2018


Unusual coexistence of Ménétrier disease with adenocarcinoma of the esophagogastric junction: A case report and review of the literature

Olga Prokopchuk Santiago Moreno-Ordaz Norbert Hüser Jeannine Bachmann Björn Konukiewitz Andrea Delgado-Picolomini Helmut Friess Marc E. Martignoni

Case Report-Integrative Cancer Science and Therapeutics (ICST)

June 15, 2018


Mutant p53 hinges between epithelial-mesenchymal transition and cancer stem cells

Hilla Solomon Ira Kogan Varda Rotter

Commentary-Integrative Cancer Science and Therapeutics (ICST)

June 23, 2018


CD44v9 and CD98hc is the marker of cancer stem cells in HNSCC

Yohei Kawasaki Yasufumi Omori

Mini-Review-Integrative Cancer Science and Therapeutics (ICST)

June 25, 2018


Glioblastoma treatment: Where to now?

Thomas MB Ware Hong-Jian Zhu

Review Article-Integrative Cancer Science and Therapeutics (ICST)

June 28, 2018


Utilizing NMR to study RNA- and compound-binding mechanisms of Musashi-1, a stem/progenitor cell marker in various normal and cancer cells

Takashi Nagata

Commentary-Integrative Cancer Science and Therapeutics (ICST)

April 02, 2018


Progress of novel compounds with anticancer activity

Jianping Yong Mingxue Yang Canzhong Lu Xiaoyuan Wu

Commentary-Integrative Cancer Science and Therapeutics (ICST)

April 03, 2018


The role of PTH in mouse skin tumorigenesis

Kazuhiro Okumura Megumi Saito Yuichi Wakabayshi

Mini Review-Integrative Cancer Science and Therapeutics (ICST)

April 06, 2018


PD-1/PD-L1 immune checkpoint inhibitors in advanced cervical cancer

Ozlen Saglam Jose Conejo-Garcia

Review Article-Integrative Cancer Science and Therapeutics (ICST)

Apr 14, 2018


Prospective evaluation of quality-of-life outcomes following orthotopic neobladder and ileal conduit diversion after radical cystectomy

Parier Bastien Neuzillet Yann Huyghe Eric Roupret Morgan Larre Stephane Pfister Christian Mottet Nicolas Irani Jacques

Research Article-Integrative Cancer Science and Therapeutics (ICST)

Apr 24, 2018


Natural cancer-killing activity of human granulocytes

Wenjun Le Zheng Cui

Review Article-Integrative Cancer Science and Therapeutics (ICST)

February 06, 2018


DeltaNp63 expression is a biomarker to predict survival after recurrence of upper urinary tract urothelial carcinoma

Yujiro Hayashi Kazutoshi Fujita Takahiro Yoshida Taigo Kato Atsunari Kawashima Takeshi Ujike Akira Nagahara MotohideUemura Masahiro Inoue Hiroaki Fushimi Ryoichi Imamura Seiji Yamaguchi Hiroshi Miyamoto Norio Nonomura

Research Article-Integrative Cancer Science and Therapeutics (ICST)

February 24, 2018


Study protocol for a phase IVsingle-center, randomized trial to evaluate theefficacy and safety of orento (AJapanese herbal (Kampo) medicines)for oral mucositis in patients withhead and neck cancer receivingchemoradiationtherapy

Takao Namiki Rintaro Harada Natsuko Nozaki-Tagucuhi Yoshiro Hirasaki ShoTakahashi RyoTakamura

Research Article-Integrative Cancer Science and Therapeutics (ICST)

February 25, 2018


Multimodal assessment of mammogram, ultrasound and clinical palpation in relation to pathological size of breast carcinoma

Fadzli F Rahmat K Mohd-Shah MN Muridan R Nawawi O Rozalli FI Looi LM Yip CH

Research Article-Integrative Cancer Science and Therapeutics (ICST)

February 26, 2018


Secreted glycoprotein YKL-40: A potential cancer biomarker and therapeutic target

Rong Shao

Commentary-Integrative Cancer Science and Therapeutics (ICST)

February 27, 2018


Volume 4

Advances in high-dimensional mass cytometry cell and tissue analyses for translational biomarker discovery

Elma Kadic Ilona Kariv

Review Article-Integrative Cancer Science and Therapeutics (ICST)

Oct 29, 2017


Targeted radiotherapy of neuroblastoma: Future directions

Mathias Tesson Colin Rae Donna L Nile Mark N Gaze Robert J. Mairs

Commentary-Integrative Cancer Science and Therapeutics (ICST)

Oct 29, 2017


Renal cell carcinoma with osseous metaplasia: A case report and literature review

Heather Maioli Meenal Sharma Genevieve M. Crane Guan Wu Hiroshi Miyamoto

Case Report-Integrative Cancer Science and Therapeutics (ICST)

Oct 30, 2017


Preventive treatment of sun-damaged skin: Topical treatment of actinic keratosis can prevent surgery in non-melanoma-skin-cancer

Daisy Kopera

Commentary-Integrative Cancer Science and Therapeutics (ICST)

Dec 29, 2017


Glycolysis is a promising target for encapsulation nano-therapeutic molecules against cancer cells

Nemany A.N. Hanafy

Commentary-Integrative Cancer Science and Therapeutics (ICST)

Dec 26, 2017


The GAIA (CLL13) trial – an international, randomized, four-arm study for first line treatment of physically fit CLL patients without del17p or TP53 mutation

von Tresckow J Bahlo J Niemann CU Kater AP Fink AM Fischer K Ritgen M Kreuzer KA
Stilgenbauer S van Oers R Hartmann Geisler C Hallek M Eichhorst B

Perspective-Integrative Cancer Science and Therapeutics (ICST)

Sep 28, 2017


The Boolean Kinetics of signal transduction

Robert C. Jackson

Review Article-Integrative Cancer Science and Therapeutics (ICST)

Oct 14, 2017


Detection of E6/E7 human papilloma virus (HPV) transcripts in lymph nodes of patients with cervical cancer

Jorge Alejandro Basiletti Alejandro Soderini María Alejandra Picconi Nicasio Cuneo Silvia Vornetti Mercedes Rodríguez de la Peña Juan Mural Claudia Kottar Cecilia Lagues María Graciela Etcheverry Diego Zurita Adriana Greco Elsa Haas Carlos Reyes Lidia Virginia Alonio

Review Article-Integrative Cancer Science and Therapeutics (ICST)

Oct 17, 2017


Prognosis of older patients with low-grade glioma: A retrospective study

Priya Kumthekar Vaibhav Patel Carly Bridge Alfred Rademaker Irene Helenowski Maciej M. Mrugala Jason K. Rockhill Sean Grimm Kristin R. Swanson Jeffrey Raizer

Research Article-Integrative Cancer Science and Therapeutics (ICST)

Oct 23, 2017


Use of metal-containing polymers as potential anticancer agents

Charles E. Carraher Jr Michael R. Roner

Review Article-Integrative Cancer Science and Therapeutics (ICST)

Oct 25, 2017


How to manage an intraoperative endoleak following left pneumonectomy with aortic wall en-bloc resection in an invasive lung cancer after aortic endoprosthesis insertion

Antonio Francisco Honguero Martínez Pablo León Atance Martín Landaluce Chaves María Dolores García Jiménez

Case Report-Integrative Cancer Science and Therapeutics (ICST)

Oct 27, 2017


The neutrophil-to-lymphocyte ratio is an effective prognostic marker in localized upper urinary tract urothelial carcinoma treated with nephroureterectomy

Mari Ohtaka Takashi Kawahara Taku Mochizuki Hiroaki Ishida Shinnnosuke Kuroda Moeka Shinbori Yusuke Hattori Jun-ichi Teranishi Kazuhide Makiyama Yasuhide Miyoshi Yasushi Yumura Hiroshi Miyamoto Masahiro Yao Hiroji Uemura

Research Article-Integrative Cancer Science and Therapeutics (ICST)

Aug 02, 2017


Genetic alterations and diagnosis in Ewing sarcoma: A review

Débora Cavalheiro dos Santos Letícia da Cruz Evangelista Leandra Ernst Kerche-Silva

Review Article-Integrative Cancer Science and Therapeutics (ICST)

Aug 08, 2017


Studying of non-malignant tumors and the added clarifications

M. Raafat El-Gewely

Editorial-Integrative Cancer Science and Therapeutics (ICST)

Aug 26, 2017


Factors influencing sleep disorders in cancer patients receiving outpatient chemotherapy

Ayako Ura Yoko Ishibashi Kaori Maki Tamami Ueno Kumiko Yoshida Ikuko Miyabayashi

Research Article

Aug 27, 2017


Human tumor slice cultures for cancer research and drug testing

Sonja Kallendrusch Justus Körfer Florian Lordick Ingo Bechmann

Review Article

Aug 29, 2017


The clinical characteristics and prognosis of ovarian endometrioid carcinoma

Jin XY Zhang WP Wu MF

Research Article-Integrative Cancer Science and Therapeutics (ICST)

June 05, 2017


Challenges of reconstructing a large frontal defect following electrical burns in a resource limited environment: Our experience

Adeola Davis Sunday Okeke Uche Albert Agbara Rowland Onyebuchi Polycarp

Case Report-Integrative Cancer Science and Therapeutics (ICST)

June 15, 2017


ZKSCAN3 expression in urothelial carcinoma of the upper urinary tract and its impact on patient outcomes

Mehrsa Jalalizadeh Satoshi Inoue Kazutoshi Fujita Hiroki Ide Taichi Mizushima Seiji Yamaguchi Hiroaki Fushimi Norio Nonomura Hiroshi Miyamoto

Research Article-Integrative Cancer Science and Therapeutics (ICST)

June 19, 2017


Assessment of DNA methylation patterns in breast tumours and apparently healthy subjects in Anambra state, Nigeria

Michael Chukwudi Ezeani Charles Chinedum Onyenekwe Samual Chukwuemeka Meludu Gabriel Udeze Chianakwana Daniel Chukwuemeka Anyiam Chiemelu Dickson Emegoakor Comfort Nne Akujobi Ujuamala Uloma Ezeani Ochonma Amobi Egwuonwu Grace I Amilo

Research Article-Integrative Cancer Science and Therapeutics (ICST)

June 22, 2017


Epithelial-mesenchymal transition in cancer: An overview

Fabiano Santos Ramos Letícia Wons Iglenir João Cavalli Enilze M.S.F. Ribeiro

Review Article-Integrative Cancer Science and Therapeutics (ICST)

June 23, 2017


Prospective increase in the training chance for nurses to learn radiation

Nami Yoshida Yoshimasa Miyazaki Mitsuru Nenoi

Perspective-Integrative Cancer Science and Therapeutics (ICST)

June 23, 2017


Lipid metabolism: An alternative Achille’s heel in lymphomas?

Pier Paolo Piccaluga Axel Visani Cristiano Peron Flavia Rigotti Lorenzo Leoncini Giuseppe Visani

Editorial-Integrative Cancer Science and Therapeutics (ICST)

June 28, 2017


Renin-angiotensin system and cancer: A review

Matthew J Munro Agadha C Wickremesekera Paul F Davis Reginald Marsh Swee T Tan Tinte Itinteang

Review Article-Integrative Cancer Science and Therapeutics (ICST)

March 29, 2017


The expression of HMGB1 and the receptor for advanced glycation end products (RAGE) in epithelial ovarian cancer

Jiheum Paek Young Tae Kim

Research Article-Integrative Cancer Science and Therapeutics (ICST)

April 03, 2017


Lifestyle factors and the risk of kidney and bladder cancer in the Japanese population: A mini-review

Masakazu Washio Mitsuru Mori Akiko Tamakoshi

Review Article-Integrative Cancer Science and Therapeutics (ICST)

April 24, 2017


Current experience in intraocular fine needle aspiration biopsy in Mexican-Mestizo population

Daniel Moreno-Páramo Marcelo Baizabal Castro Fernando Pérez-Pérez Ivette Hernández-Ayuso Dolores Ríos y Valles-Valles Leonora Chávez-Mercado Abelardo A. Rodríguez-Reyes

Review Article-Integrative Cancer Science and Therapeutics (ICST)

April 24, 2017


Nano drug delivery systems for ovarian cancer therapy

Canan Hascicek Ozge Gun

Mini Review-Integrative Cancer Science and Therapeutics (ICST)

April 25, 2017


Tumor heterogeneity: An overlooked issue in cancer therapeutics

Tomas Koltai

Review Article-Integrative Cancer Science and Therapeutics (ICST)

April 25, 2017


Oxazaphosphorine cytostatics: A good way to create better is to study old oxazaphosphorines

Georg Voelcker

Mini Review-Integrative Cancer Science and Therapeutics (ICST)

April 26, 2017


RIG-I: A double-edged sword between inflammation and cancer

Ying-Yu Cui

Editorial-Integrative Cancer Science and Therapeutics (ICST)

April 28, 2017


Cancer caused by UV radiation from nanoparticles in GM food

Thomas Prevenslik

Research Article-Integrative Cancer Science and Therapeutics (ICST)

January 14, 2017


A review of the impact of obesity on common gastrointestinal malignancies

Somashekar G. Krishna Hisham Hussan Zobeida Cruz-Monserrate Lanla F. Conteh Khalid Mumtaz Darwin L. Conwell

Review Article-Integrative Cancer Science and Therapeutics (ICST)

January 18, 2017


Molecularly confirmed Li-Fraumeni-like syndrome in a patient with breast cancer and a low pre-test probability for harboring a germline CHEK2 truncation

Steven Sorscher

Case Report-Integrative Cancer Science and Therapeutics (ICST)

February 17, 2017


Combined immunoglobulin G kappa nephropathy: monoclonal immunoglobulin deposition disease and proximal tubulopathy: monoclonal gammopathy of renal significance or smoldering multiple myeloma? Case report and review of literature

Elena V Zakharova Ekaterina S Stolyarevich Olga A Vorobyeva Eugeny A Nikitin

Case Report-Integrative Cancer Science and Therapeutics (ICST)

February 17, 2017


Long-term administration of Active Hexose Correlated Compound as a dietary supplement to a patient after breast cancer surgery and chemotherapy: A case report

Koji Wakame Jun Takanari Atsuya Sato Satomi Shirakawa Ken-ichi Komatsu

Case Report-Integrative Cancer Science and Therapeutics (ICST)

February 27, 2017


Ewing sarcoma of the testis: A case report and review of the literature

Javier Peinado-Serrano David Chinchón-Espino Michele Biscuola Maria José Ortiz-Gordillo

Case Report-Integrative Cancer Science and Therapeutics (ICST)

February 27, 2017


BRCA1 and BRCA2 mutations and treatment strategies for breast cancer

Inês Godet Daniele M. Gilkes

Review Article-Integrative Cancer Science and Therapeutics (ICST)

February 27, 2017


Pure nongestational ovarian choriocarcinoma: A scoping review

Alison Garrett Amy Knehans Rebecca Phaeton Joshua P. Kesterson

Review Article-Integrative Cancer Science and Therapeutics (ICST)

February 28, 2017


Cavernous hemangioma arising in an intramural leiomyoma

Zeliha Esin Celik Senem Bastoklu Tolgay Tuyan Ilhan Cetin Celik

Case Report-Integrative Cancer Science and Therapeutics (ICST)

February 28, 2017


Volume 3

Electrical impedance spectroscopy for breast cancer diagnosis: Clinical study

Z. Haeri M. Shokoufi M. Jenab R. Janzen F.Golnaraghi

Research Article-Cancer Science and Therapeutics (ICST)

December 16, 2016


Historical highlights on cancer invading the portal vein

Wilson I. B. Onuigbo

Opinion-Cancer Science and Therapeutics (ICST)

December 19, 2016


Cytokines and immune response in vasculitis of peripheral nervous system: Tumor necrosis factor-alpha and pro-inflammatory cytokines in vaculitis of peripheral nervous system: A comparative immunohistochemical study on systemic and non-systemic vasculitic neuropathy

Giovanni Antioco Putzu

Research Article-Cancer Science and Therapeutics (ICST)

December 23, 2016


Cardiac toxicities associated with cancer therapy

Eric Chang Sanjay R Jain

Review Article-Cancer Science and Therapeutics (ICST)

December 24, 2016


Exploration of food materials and components showing the suppressing effect on absorption of strontium and the promoting effect on excretion of cesium in vivo

Yuya Uehara Kana Ishizuka Yuko Shimamura Michiko Yasuda Kayoko Shimoi Shuichi Masuda

Research Article-Cancer Science and Therapeutics (ICST)

December 26, 2016


Large cell neuroendocrine carcinoma (LCNEC) of the ovary: A case report and review of the literature

Allyson Jang Jordan M. Newell Rebecca Phaeton Joshua P. Kesterson

Case Report-Integrative Cancer Science and Therapeutics (ICST)

December 28, 2016


An intracranial dermoid tumour with large right parietal infarct- A rare case report

Sarkar S Islam MM Avijit D Hossen MK Dasgupta A Saha S Sazib SMF Khan MN

Case Report-Integrative Cancer Science and Therapeutics (ICST)

December 28, 2016


High dose intravenous vitamin c and metastatic pancreatic cancer: Two cases

Michael J. González Miguel J. Berdiel Jorge R Miranda-Massari Desireé López Jorge Duconge Joshua L. Rodriguez Pedro Adrover c

Case Report-Integrative Cancer Science and Therapeutics (ICST)

December 29, 2016


Thin melanoma and sentinel lymph node biopsy: A difficult relationship between them

JC Rodriguez Otero R Fernández Bussy A Bergero M Gorosito G Salerni MS Dagatti R Villavicencio R Staffieri SM Batallés V Milatich J Rodriguez Otero SM Pezzotto

Research Article-Integrative Cancer Science and Therapeutics (ICST)

December 29, 2016


Microenvironment and its role in acquiring drug resistance of leukemia treatment

Malak Yahia Mohammed Qattan

Mini- Review-Integrative Cancer Science and Therapeutics (ICST)

December 30, 2016


M2-like macrophages and tumor-associated macrophages: overlapping and distinguishing properties en route to a safe therapeutic potential

Ofer Guttman Eli C. Lewis

Review Article-Cancer Science and Therapeutics (ICST)

August 29, 2016


Multicentral meningothelial meningioma: a case of death

Mansueto Gelsomina Emanuele Capasso Antonio Lombardi Pieri Maria Claudio Buccelli

Case Report-Cancer Science and Therapeutics (ICST)

September 12, 2016


The clinical characteristics of oral squamous cell carcinoma in patients attending the Medunsa Oral Health Centre, South Africa

Bouckaert M Munzhelele TI Lemmer J Khammissa RAG

Research Article-Cancer Science and Therapeutics (ICST)

October 12, 2016


Distinguishing malignant from benign prostate using content of 17 chemical elements in prostatic tissue

Vladimir Zaichick Sofia Zaichick

Research Article-Cancer Science and Therapeutics (ICST)

October 22, 2016


Choledochal cysts- Classification, physiopathology, and clinical course

Fatih Altıntoprak Mustafa Yener Uzunoğlu Enis Dikicier İsmail Zengin

Research Article-Cancer Science and Therapeutics (ICST)

October 24, 2016


Clinical applications of mouse models for breast cancer engaging HER2/neu

Elizabeth A. Fry Pankaj Taneja Kazushi Inoue

Review Article-Cancer Science and Therapeutics (ICST)

October 28, 2016


A review of invasive lobular carcinoma of the breast: Should it be treated like invasive ductal carcinoma?

Lee Joycelyn Jie Xin Lee Guek Eng

Mini Review-Cancer Science and Therapeutics (ICST)

October 29, 2016


Lymphorrhea in gastric cancer patients

Bandar Ali

Short Communication-Integrative Cancer Science and Therapeutics (ICST)

May 30, 2016


Application of molecular targeted therapy for refractory metastatic thyroid cancers

Timothy Allen Lee Meller

Review Article-Integrative Cancer Science and Therapeutics (ICST)

June 17, 2016


The role of myeloid-derived suppressor cells in the relationship between chronic obstructive pulmonary disease and lung cancer

Sergio Scrimini Jaume Pons Jaume Sauleda

Review Article-Integrative Cancer Science and Therapeutics (ICST)

June 23, 2016


Characterizing heterogeneic tumor profiles with an integrated companion diagnostics approach

Sergio Scrimini Jaume Pons Jaume Sauleda

Review Article-Integrative Cancer Science and Therapeutics (ICST)

July 01, 2016


Cytoreductive surgery and heated intrathoracic chemotherapy for thoracic extension of Pseudomyxoma peritonei

Mathew P. Doyle Claudia I. Villanueva Samuel Davies Gary G. Fermanis Matthew D. Horton David L. Morris

Review Article-Integrative Cancer Science and Therapeutics (ICST)

July 03, 2016


Peri-tumoral neural niche in brain metastasis from breast cancer

Rahul Jandial Khairul I Ansari

Image Articl-Cancer Science and Therapeutics (ICST)

July 04, 2016


Microorganisms and cancer of the oral cavity

Kaoru Kusama Harumi Inoue Yuji Miyazaki Kentaro Kikuchi Hideaki Sakashita Kuniyasu Ochiai

Review Article-Cancer Science and Therapeutics (ICST)

July 08, 2016


Genetic determinants of psychic resilience after a diagnosis of cancer

Mette Christensen Antonio Drago

Review Article-Cancer Science and Therapeutics (ICST)

July 25, 2016


Acetogenins of Annona muricata leaves: Characterization and potential anticancer study

Nik Nurul Najihah Nik Mat Daud Harisun Ya’akob Mohamad Norisham Mohamad Rosdi

Research Article-Cancer Science and Therapeutics (ICST)

Aug 14, 2016


The rosebud- twenty-five years of tumor dormancy mimicks locally advanced non-small cell lung cancer

D. Staudenmann M. Gugger Ph. Dumont St. Zimmerman

Case Report-Cancer Science and Therapeutics (ICST)

Aug 23, 2016


BH3 mimetics: Their action and efficacy in cancer chemotherapy

Wataru Nakajima Nobuyuki Tanaka

Review Article-Integrative Cancer Science and Therapeutics (ICST)

April 26, 2016


11β-hydroxysteroid dehydrogenase type II: a Potential target for prevention of colonic tumorigenesis

Xin Wang Raymond C. Harris Ming-Zhi Zhang

Review Article-Integrative Cancer Science and Therapeutics (ICST)

April 29, 2016


Discussion on the tumor treatment of traditional chinese medicine:Discover the new therapeutic strategy

Xiaojuan Sun Fucheng Hu

Review Article-Integrative Cancer Science and Therapeutics (ICST)

April 29, 2016


Modulation of 5-Aminolevulinic acid mediated photodynamic therapy induced cell death in a human lung adenocarcinoma cell line

Teijo MJ Diez B Batlle A Haydée Fukuda

Research Article-Integrative Cancer Science and Therapeutics (ICST)

April 29, 2016


Integrative approaches in breast cancer patients: A mini-review

Stefano Magno Filippone Alessio Assunta Scaldaferri Virgilio Sacchini Federica Chiesa

Review Article-Integrative Cancer Science and Therapeutics (ICST)

May 05, 2016


Macrophages directed approaches are paramount for effective cancer immunotherapies

Vinod Nadella Sandhya Singh Hridayesh Prakash

Review Article-Integrative Cancer Science and Therapeutics (ICST)

May 05, 2016


Primary vaginal melanoma in the setting of mucosal melanosis - A case report and literature review

Deirdre Kelly Jack Gleeson Geoffrey Watson Graham Woods Connor O’Keane John Mc Caffrey

Case Report-Integrative Cancer Science and Therapeutics (ICST)

May 07, 2016


Kikuchi-Fujimoto necrotizing lymphadenitis: A rare case of generalized lymphadenopathy

Charlotte Lansky Hasaam Sheikh Mohamad Lazkani Cheryl O’Malley

Research Article-Integrative Cancer Science and Therapeutics (ICST)

May 09, 2016


Placenta-specific protein 1 (PLAC1) is a unique onco-fetal-placental protein and an underappreciated therapeutic target in cancer

Eric J. Devor

Review Article-Integrative Cancer Science and Therapeutics (ICST)

May 09, 2016


An overview of integrative analysis in cancer studies

Shinuk Kim Taesung Park

Review Article-Integrative Cancer Science and Therapeutics (ICST)

May 10, 2016


A single patient study of high dose isoflavones to enhance gemzar chemotherapy in post resection and post chemoradiation adjuvant treatment of pancreatic adenocarcinoma

Adam J. Nehr III Barbara J. Nehr

Case Report-Integrative Cancer Science and Therapeutics (ICST)

February 25, 2016


Adrenomedullin in pancreatic carcinoma: A case-control study of 22 patients

D'Angelo Francesco Letizia Claudio Antolino Laura La Rocca Mara Aurello Paolo Ramacciato Giovanni

Research Article-Integrative Cancer Science and Therapeutics (ICST)

March 14, 2016


The high effect of chemomobilization with high-dose topside and G-CSF in autologous hematopoietic peripheral blood stem cell transplantation (Single centre experience)

Sebnem Izmir Guner Mustafa Teoman Yanmaz Ahmet Selvi Cıgdem Usul

Research Article-Integrative Cancer Science and Therapeutics (ICST)

March 21, 2016


An importance of clinical proteomics for personalized medicine of lung cancer subtypes

Yasufumi Kato Toshihide Nishimura Jun Matsubayashi Kinya Furukawa Masaharu Nomura Kiyonaga Fujii Haruhiko Nakamura Harubumi Kato

Review Article-Integrative Cancer Science and Therapeutics (ICST)

March 25, 2016


Erosion of bowel by catheter of peritoneal access device during intraperitoneal chemotherapy: A case report and PRISMA-driven systematic review

Hung-Hsin Lin Hou-Hsuan Cheng Yi Chang Yen-Hou Chang Chi-Mu Chuang

Review Article-Integrative Cancer Science and Therapeutics (ICST)

March 28, 2016


Immunotherapy and colon cancer

Timothy Allen Abdullateef Al-Hadeethi

Review Article-Integrative Cancer Science and Therapeutics (ICST)

April 04, 2016


MRI-guided radiotherapy: Opening our eyes to the future

Amar U. Kishan Percy Lee

Review Article-Integrative Cancer Science and Therapeutics (ICST)

April 06, 2016


Imaging in animal models

Eika Webb Ming Yuan Nicholas R Lemoine Yaohe Wang

Review Article-Integrative Cancer Science and Therapeutics (ICST)

April 08, 2016


Toll-like receptors and breast cancer

Lijie Sun Qiuli Jiang Yifan Zhang Hongbin Liang Huan Ren Dekai Zhang

Review Article-Integrative Cancer Science and Therapeutics (ICST)

April 25, 2016


The possible role of embryonic polarity axes for the normalization of tissue function induced by the interaction between human bilateral parts

Ming Cheh Ou Dennis Ou Chung Chu Pang

Research Article-Integrative Cancer Science and Therapeutics (ICST)

December 21, 2015


A short-term retrospective analysis of the clinical, histopathological and immunohistochemical aspects in endometrial malignancy

Tiberiu Augustin Georgescu Monica Cîrstoiu Mariana Costache Anca Lăzăroiu Adrian Dumitru

Research Article-Integrative Cancer Science and Therapeutics (ICST)

January 11, 2016


A case of advanced hepatocellular carcinoma cured with antiviral therapy and sorafenib

Steven Krawitz Flavius Guglielmo Hie-Won Hann

Case Report-Integrative Cancer Science and Therapeutics (ICST)

January 15, 2016


Corticosteroid-induced case of a lightning pheochromocytoma crisis:Insight into glucocorticoid receptor expression

Marie-France Dupont Marie-Claude Battista Émilie Comeau Myrna Atallah-Chababi Patrice Perron 5andMartine Chamberland

Case Report-Integrative Cancer Science and Therapeutics (ICST)

January 23, 2016


Subjective and objective evaluation of voice and pulmonary function in partial laryngectomised patients

Mehmet Gökhan Demir Mustafa Paksoy Arif Şanlı Sevtap Akbulut Sedat Aydın Hüseyin Baki Yılmaz Mehmet Bilgin Eser

Research Article-Integrative Cancer Science and Therapeutics (ICST)

January 30, 2016


Comparison of exposure levels of carotid artery in T1-2 glottic cancer patients undergoing radiotherapy with different modalities: A simulation-based dosimetric study

Gonca Hanedan Uslu Emine Canyilmaz Fatma Colak Burcin Hazeral Ahmet Yasar Zengin Hüseyin Göçmez Adnan Yoney

Research Article-Integrative Cancer Science and Therapeutics (ICST)

January 30, 2016


Management of hypercalcemia of malignancy

Sonia Amin Thomas (Sonia Patel) Soo-Hwan Chung

Review Article-Integrative Cancer Science and Therapeutics (ICST)

February 06, 2016


Metformin associates with lower on colorectal neoplastic risk in African American diabetic patients

AnahitaShahnazi Armana Saeed Gail Nunlee-Bland Yasin Mustafa Hassan Brim Mehdi Nouraie Hassan Ashktorab

Research Article-Integrative Cancer Science and Therapeutics (ICST)

February 08, 2016


Obesity as a risk factor for prostate cancer: A clinical review

Tushar Trivedi Marsha Samson Olubunmi Orekoya

Review Article-Integrative Cancer Science and Therapeutics (ICST)

February 11, 2016


Diabetes-associated dysregulated cytokines and cancer

Yong Wu Yunzhou Dong Yanjun Liu Jay Vadgama

Review Article-Integrative Cancer Science and Therapeutics (ICST)

February 15, 2016


Volume 2

Alpha1-antitrypsin, an endogenous immunoregulatory molecule: distinction between local and systemic effects on tumor immunology

Ofer Guttman Gabriella S Freixo-Lima Eli C Lewis

Review Article-Integrative Cancer Science and Therapeutics (ICST)

October 24, 2015


Evaluation of the impact of treatment delays and dose reductions in human ovarian cancer orthotopic mouse models

Scott Mosley Jing-Hong Chen Anjali Gaikwad Elizabeth K. Nugent Judith A. Smith

Research Article-Integrative Cancer Science and Therapeutics (ICST)

October 27, 2015


Comparing Chinese and American oncology practice patterns using precision therapy for non-small cell lung cancer

Zhang Ming HaoXinbao Han LiangFu Hu Honglin AoRui Zhu Xueqiang He Yangke Chen Lin Ming Zeng

Clinical Survey-Integrative Cancer Science and Therapeutics (ICST)

October 31, 2015


Monitoring Bip promoter activation during cancer cell growth by bioluminescence imaging at the single-cell level

Tomohisa Horibe Aya Torisawa Ryohsuke Kurihara Ryutaro Akiyoshi Yoko Hatta-Ohashi Hirobumi Suzuki Koji Kawakami

Research Article-Integrative Cancer Science and Therapeutics (ICST)

November 03, 2015


Risk factors for cost-related medication non-adherence among older patients with cancer

James X. Zhang David O. Meltzer

Research Article-Integrative Cancer Science and Therapeutics (ICST)

November 06, 2015


Then there were none!

Veronica J. James Judith M. O'Malley Ford Jason Buttigieg

Letter to Editor-Integrative Cancer Science and Therapeutics (ICST)

December 01, 2015


Pseudomyxoma peritonei, a rare tumors of the abdomen: Palliative treatment and response to low-dose capecitabine and/or bevacizumab

Stefanis Aristotelis Albertsson Maria

Case Report-Integrative Cancer Science and Therapeutics (ICST)

December 04, 2015


Interprofessional care to improve patient-centered approach in breast cancer: a case-report regarding the management of concomitant psychiatric symptomatology

Paola Arnaboldi Serena Oliveri Gabriella Pravettoni

Case Report-Integrative Cancer Science and Therapeutics (ICST)

December 10, 2015


Systemic inflammation in malignant pleural mesothelioma: Is neutrophyl-to-lymphocyte ratio a prognostic index?

Felice MucilliFelice Mucilli Pierpaolo Camplese Luigi Guetti Barbara Maggi Marco Prioletta Mirko Barone Antonia Rizzuto Rosario Sacco

Research Article-Integrative Cancer Science and Therapeutics (ICST)

December 15, 2015


Oncogenic mutational/epigenetic events: Deterministic, stochastic or random: Implications for hypoxic cancer cells and tumor heterogeneity

Anderson KM Rubenstein M Guinan P Patel MK

Research Article-Integrative Cancer Science and Therapeutics (ICST)

January 05, 2015


Fatigue in patients with colorectal cancer treated with capecitabine and oxaliplatin

Sá Lilian A Vettori Josiane C Moreira Cláudia LR Leandro Miraya S Tirapelli Daniela PC Perdoná Gleici SC Souza Hayala CC Oliveira Harley F Santos Fabiana N Rapatoni Liane Ribeiro Karen B Almeida Thiago CL Feres Omar Rocha José JRR Peria Fernanda M

Research Article-Integrative Cancer Science and Therapeutics (ICST)

January 27, 2015


Expression and regulation of bone morphogenetic protein 4 in hepatocellular carcinoma

Xiaotong Wang Qingguo Wang Weisi Kong Gerald Y Minuk Frank J Burczynski Emmanuel Ho Yuewen Gong

Research Article-Integrative Cancer Science and Therapeutics (ICST)

January 29, 2015


The origin of circumscribed necroses and perinecrotic niches in glioblastoma multiforme: An additional hypothesis

Davide Schiffer Laura Annovazzi Marta Mazzucco Marta Mellai

Mini Review-Integrative Cancer Science and Therapeutics (ICST)

February 03, 2015


Shedding by ADAM10 and ADAM17 is associated with progression of adult T-cell leukemia/lymphoma

Shigeki Takemoto Tomohiro Kozako Ratiorn Pornkuna

Short Communication-Integrative Cancer Science and Therapeutics (ICST)

February 05, 2015


Delphinidin and cyanidin exhibit antiproliferative and apoptotic effects in MCF7 human breast cancer cells

Jessica Tang Emin Oroudjev Leslie Wilson George Ayoub

Research Article-Integrative Cancer Science and Therapeutics (ICST)

February 09, 2015


Effects of Chk1 inhibitor or paclitaxel on cisplatin-induced cell-cycle kinetics and survival in parental and cisplatin-resistant HeLa cells expressing fluorescent ubiquitination-based cell cycle indicator (Fucci)

Chisato Yamada Atsushi Kaida Kohei Okuyama Kiyoshi Harada Masahiko Miura

Research Article-Integrative Cancer Science and Therapeutics (ICST)

February 09, 2015


The endometrial cancer in Southern Tunisia: Investigation about 52 cases

Kebaili Sahbi Trigui K Louati D Charfi S Ben Hlima S Daoud J Chaabane K Amouri H

Research Article-Integrative Cancer Science and Therapeutics (ICST)

February 12, 2015

SERCA-as-a-target-for-cancer-therapies

Denise Casemore Chengguo Xing

Research Article-Integrative Cancer Science and Therapeutics (ICST)

February 26, 2015


An audit of inter-observer variability in Gleason grading of prostate cancer biopsies: The experience of central pathology review in the North West of England

Emile N Salmo

Research Article-Integrative Cancer Science and Therapeutics (ICST)

March 02, 2015


Quality of life among Brazilian women having undergone surgery for breast cancer: Validity and reliability of the Quality of life Questionnaire (EORTC QLQ-C30) and Breast Cancer Module (QLQ BR-23)

Ana Silvia Diniz Makluf Alexandre de Almeida Barra Rosângela Corrêa Dias Cristovão Pinheiro de Barros

Research Article-Integrative Cancer Science and Therapeutics (ICST)

March 08, 2015


Towards an integrated model of defense in gynecological cancer. Psychoneuroimmunological and psychological factors, between risk and protection in cancer: A review

Chiara Cosentino Carlo A. Pruneti

Research Article-Integrative Cancer Science and Therapeutics (ICST)

March 09, 2015


Effect of glycosylated vitamin D binding protein complexed with oleic acid on human myeloma and Hodgkin’s lymphoma cultures

Jacopo J.V. Branca Rodney J Smith Emma Ward Marco Ruggiero

Research Article-Integrative Cancer Science and Therapeutics (ICST)

March 17, 2015


Cytotoxicity of gemcitabine-loaded thermosensitive liposomes in pancreatic cancer cell lines

Kevin Affram Ofonime Udofot Edward Agyare

Research Article-Integrative Cancer Science and Therapeutics (ICST)

April 16, 2015


Retrospective review on: Local breast therapy in addition to systemic therapy in de-novo metastatic breast cancer

Tahani Nageeti Raid Jastania

Research Article-Integrative Cancer Science and Therapeutics (ICST)

May 02, 2015


Feasibility of liposuction for treatment of arm lymphedema from breast cancer: A prospective study and review of the literature

Erin Louise Doren Paul David Smith Weihong Sun MensuraLacevic William Fulp Rebecca Reid Christine Laronga

Research Article-Integrative Cancer Science and Therapeutics (ICST)

June 04, 2015


Rethinking NM23: An extracellular role for NDPKinase in breast cancer

Iain L. O. Buxton Senny Nordmeier

Review Article-Integrative Cancer Science and Therapeutics (ICST)

June 03, 2015


Antioxidants therapy: An alternative for androgen deprivation therapy (ADT) to decrease prostate-specific antigen (PSA) level

Mohammad Reza Naghii Mehdi Hedayati Mahmood Mofid

Research Article-Integrative Cancer Science and Therapeutics (ICST)

June 06, 2015


The cytogenetic and molecular analysis of chronic myeloid leukemia in a tertiary care hospital of Sindh, Pakistan

Ikramdin Ujjan Anwar Ali Akhund Abdul Mannan Baig Ghulam Shah Nizamani

Research Article-Integrative Cancer Science and Therapeutics (ICST)

June 17, 2015


Extrinsic targeting strategies against acute myeloid leukemic stem cells

Noureldien H. E. Darwish Shaker A. Mousa

Review Article-Integrative Cancer Science and Therapeutics (ICST)

June 22, 2015


Intrinsic targeting strategies against acute myeloid leukemic stem cells

Noureldien H. E. Darwish Shaker A. Mousa

Review Article-Integrative Cancer Science and Therapeutics (ICST)

June 22, 2015


Navigating commercial approval of therapeutics: The evolution of the United States Food and Drug Administration

Dillon Jarrell Megan Hamrick Michaela Good Anna Chopp Mark Brown

Commentry-Integrative Cancer Science and Therapeutics (ICST)

June 28, 2015


(+)-Aeroplysinin-1 inhibits Akt and Erk pathway signaling selectively in endothelial cells

Beatriz Martínez-Poveda Ana R. Quesada Miguel A. Medina

Research Article-Integrative Cancer Science and Therapeutics (ICST)

July 06, 2015


PKGI mediates the growth inhibitory effects of cGMP signaling in human breast cancer cells independent of β-catenin

Perrin F. Windham Paul S. Rodriguez Nicholas J. Rivers Heather N. Tinsley

Research Article-Integrative Cancer Science and Therapeutics (ICST)

July 22, 2015


Blockade of extracellular NM23 or its endothelial target slows breast cancer growth and metastasis

Nucharee Yokdang Senny Nordmeier Katie Speirs Heather R. Burkin Iain L. O. Buxton

Research Article-Integrative Cancer Science and Therapeutics (ICST)

August 04, 2015


The scopes and falls of molecular targeted therapy in gastric cancer

Vinod Vijay Subhash Wei Peng Yong

Review Article-Integrative Cancer Science and Therapeutics (ICST)

August 20, 2015


Single dose bevacizumab as treatment for symptomatic, corticosteroid-refractory pseudoprogression after chemoradiation therapy for newly diagnosed glioblastoma: A case report

Taylor M. Morris Isabelle Vallieres Andrew Attwell R Petter Tonseth Natella Jafarova David L. Saltman

Case Report-Integrative Cancer Science and Therapeutics (ICST)

August 24, 2015


Pituitary gland metastases from renal cell carcinoma: A case report and literature update

Domenico Murrone Francesco Amedeo Abbate Danilo De Paulis Renato Juan Galzio

Case Report-Integrative Cancer Science and Therapeutics (ICST)

August 27, 2015


Pleurodesis in malignant pleural effusions: Outcome and predictors of success

Hind Rafei Suha Jabak Alain Mina Arafat Tfayli

Research Article-Integrative Cancer Science and Therapeutics (ICST)

September 18, 2015


A case of unresectable small cell lung cancermore than 7 years of survival treated with cryoablation and low dose chemotherapy

Quanwang Li Tian Zhou Min Jiang Kaiwen Hu Franco Lugnani Antonio Cueto

Case Report-Integrative Cancer Science and Therapeutics (ICST)

September 19, 2015


Communicating with prostate cancer patients: Psychosocial profile and determinants of seeking psychosocial care

Laura Daeter Adriaan Visser Chantal van Harten Bert Voerman

Research Article-Integrative Cancer Science and Therapeutics (ICST)

September 21, 2015


Epiphrenic esophageal diverticulum within a leiomyoma: A rare cause of dysphagia

Omar Abdel-lah Fernández Alberto Alvarez Delgado Felipe Carlos Parreño Antonio Rodriguez

Case Report-Integrative Cancer Science and Therapeutics (ICST)

September 22, 2015


5-Fluorouracil-ınduced radiation recall dermatitis: A case report

Gonca Hanedan Uslu Emine Canyilmaz Savas Yayli Sevdegul Aydin Ahmet Yasar Zengin Adnan Yoney

Research Article-Integrative Cancer Science and Therapeutics (ICST)

September 25, 2015


BCL2L11 (BIM) deletion polymorphism, rather than BIM SNP, is an effective predictor of early molecular relapse after ABL tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia

Seiichiro Katagiri Tetsuzo Tauchi Kenichi Tadokoro Junko H. Ohyashiki Kazuma Ohyashiki

Letter to Editor-Integrative Cancer Science and Therapeutics (ICST)

September 28, 2015


Cytotoxicity of 5-fluorouracil-loaded pH-sensitive liposomal nanoparticles in colorectal cancer cell lines

Ofonime Udofot Kevin Affram Bridg’ette Israel Edward Agyare

Research Article-Integrative Cancer Science and Therapeutics (ICST)

October 09, 2015


Lysophosphatidic acid induces ME180 cell migration via its putative receptor GPR87

Ryo Saito Daisuke Furuta Shunsuke Nakajima Takuya Watanabe Shoichi Ochiai Takashi Fujita Norihisa Fujita

Research Article-Integrative Cancer Science and Therapeutics (ICST)

October 12, 2015


The unsuspected intrinsic property of melanin to transform light energy into chemical energy and the Warburg effect: Connotations in cancer biochemistry

Arturo Solis Herrera

Mini Review-Integrative Cancer Science and Therapeutics (ICST)

October 12, 2015


ABT-737 and Roscovitine induces apoptosis in a synergistic fashion in mast cells carrying the D816V KIT mutation

Katarina Lyberg Gunnar Nilsson Christine Möller Westerberg

Research Article-Integrative Cancer Science and Therapeutics (ICST)

October 16, 2015


Volume 1

Potential significance of the regucalcin gene in human carcinoma

Masayoshi Yamaguchi

Editorial-Integrative Cancer Science and Therapeutics (ICST)

Aug 01, 2014


The suppression of regucalcin gene expression may lead to hepatocarcinogenesis

Masayoshi Yamaguchi

Review Article-Integrative Cancer Science and Therapeutics (ICST)

Aug 03, 2014

Soluble CD30 and peripheral blood or pulmonary involvement of adult T-cell leukemia/lymphoma

Shigeki Takemoto Ratiorn Pornkuna

Short Communication-Integrative Cancer Science and Therapeutics (ICST)

October 02, 2014


Prognostic value of bone marker beta-crosslaps in patients with breast carcinoma

Nicole Zulauf Ingo Marzi Gerhard M Oremek

Research Article-Integrative Cancer Science and Therapeutics (ICST)

October 03, 2014


Disrupting cancer cell function by targeting mitochondria

Emily Ann Carlson Shirley ShiDu Yan

Research Article-Integrative Cancer Science and Therapeutics (ICST)

October 04, 2014


A new bidirectional intraperitoneal and systemic induction chemotherapy (BISIC) for the peritoneal metastasis from gastric cancer in neoadjuvant setting

Yonemura Y Canbay Endou Y Ishibashi H Mizumoto A Li Y Takeshita K Ichinose M Takao N Noguchi K Hirano M Glehen O Brűcher B Sugarbaker P

Research Article-Integrative Cancer Science and Therapeutics (ICST)

October 07, 2014


Assessing potential herb-drug interactions: A clinical decision-making guideline to mitigate patient risk

Shauna Birdsall Glen J Weiss

Review Article-Integrative Cancer Science and Therapeutics (ICST)

October 15, 2014

Tartrate-resistant acid phosphatase 5b as a diagnostic marker of bone metastases in patients with renal cell carcinoma

Robert Preussner Hildegund Sauer-Eppe Gerhard Maximilian Oremek

Research Article-Integrative Cancer Science and Therapeutics (ICST)

November 03, 2014


Cancer as a “mafia” within the body: A proposition of conceptual approach that seems congruent to the complex biology of the disease

Dariusz Adamek Anastazja Stoj

Letter to Editor-Integrative Cancer Science and Therapeutics (ICST)

November 09, 2014


Small molecule inhibitors as emerging cancer therapeutics

Lavanya V Mohamed Adil A.A Neesar Ahmed Arun K.Rishi Shazia Jamal

Review Article-Integrative Cancer Science and Therapeutics (ICST)

November 09, 2014


Weak burst-firing magnetic fields that produce analgesia equivalent to morphine do not initiate activation of proliferation pathways in human breast cells in culture

Nirosha J. Murugan Lukasz M M. Karbowski Michael A. Persinger

Research Article-Integrative Cancer Science and Therapeutics (ICST)

November 16, 2014


No association between TTTA short tandem repeat (STR) of the CYP19 gene and prostate cancer risk in Iranian population: A case control study

Kunihide Tanaka Farah Farzaneh Karimpur-zahmatkesh Jalil Hosseini Farkhondeh Pouresmaeili Abolfazl Movafagh Eznollah Azarghashb Mohammad Yaghoobi Reza Mirfakhraie

Research Article-Integrative Cancer Science and Therapeutics (ICST)

November 18, 2014


Topical administration of a newly devised anticancer agent: A novel concept of cancer chemotherapy

Akio Sugitachi Naoko Takahashi Kohei Kume Yukimi Ohmori Satoshi Nishizuka Yusuke Kimura Go Wakabayashi

Research Article-Integrative Cancer Science and Therapeutics (ICST)

December 15, 2014

External Databases & Indexes


  • CAS
  • ROAD
  • SciCurve Open
  • Refseek
  • WorldCat
  • Crossref
  • Google scholar
  • Pubmed*
  • SciLit
  • Electronic Journals Library (EZB)
  • German Journal Database (ZDB)
  • Scientific Indexing Services (SIS)
  • Publons

All published articles are provided with DOI and are permanently archived at Open Access Text website in PDF and HTML formats.


*Pubmed: Only selected publications will be indexed.

Submit Manuscript


Integrative Cancer Science and Therapeutics welcomes direct submissions of manuscripts from authors. You can submit your manuscript to: submissions@oatext.com ; alternatively to: editor.icst@oatext.com

Publication Charges


Integrative Cancer Science and Therapeutics is an Open Access journal and we do not charge the end user when accessing a manuscript or any article. This allows the scientific community to view, download, distribution of an article in any medium, provided that the original work is properly cited, under the term of "Creative Commons Attribution License". In line with other open access journals we provide a flat fee submission structure on the acceptance of a peer-reviewed article which covers in part the entirety of the publication pathway (the article processing charge). The process includes our maintenance, submission and peer review systems and international editing, publication and submission to global indexing and tracking organisations and archiving to allow instant access to the whole article and associated supplementary documents. We also have to ensure enough investment to secure a sustainable model which ethically, legally and financially stable.

//

The publication charges for Integrative Cancer Science and Therapeutics are USD 1990.

Frequently Asked Questions (FAQs)

Why are your charges set at these levels?

All articles published in OA Text are open access. Open Access publishing implies that all readers, anywhere in the world, are allowed unrestricted to full text of articles, immediately on publication in OA Text Journals. The Article Publication Charges pay for the editorial and production costs of the journal, for hosting the website, publishing articles online, preparing HTML , PDF and XML versions of the articles and submitting the articles in electronic citation database like CrossRef.

Our financial goals are to:

  • Recover capitalization costs;
  • Produce sufficient revenue to allow for a sustainable and scalable publishing program, under continuous development;
  • Bend the publication-charge cost downward over time.

Who will pay the APC?

Corresponding author or Co-authors has to make the payment on acceptance of the article.

When should I pay?

Corresponding author or the paying institutions should arrange for the payment once they are notified regarding acceptance of the article. APC is exempted for cases in which a wavier agreement has been made in-prior to submission.

*We request an immediate attention towards the payment as the articles will not be published unless the charges have been paid.

How do I pay?

Authors or institutions can make payments by two modes as per their convenience.

  1. Wire/Bank transfer
  2. Card payment

Note: No taxes are included in this charge, taxes will be applicable as per the policies of the country of the payee. Additional transaction charges may be levied on the author.

Can I be eligible for wavier on APC?

The waiver request will be considered on a case-by-case basis, and will be provided accordingly.

*The Waiver requests must be made during the submission process and will not be accepted after  processing of the manuscript.

Do I have to pay if my manuscript is rejected?

No, Article processing charges will not be applicable for articles rejected by the Editorial office.

Withdrawal Charges

Are reprints of my article included in the article processing charges (APCs)?

No, Article processing charges (APCs) do not include the charges for the reprints. Reprints facility is optional and should be order separately.

Special Issues


 Lung Cancer

Editor Affiliation:
Kazuya Fukuoka, MD, PhD,
Department of Medical Oncology
Sakai Hospital, Kinki University Faculty of Medicine
Japan

Submission date: December 15, 2019
Publication date: January 10, 2020

Description of the Special Issue: The special issue focuses on all areas of lung cancer from basic biology to advanced treatment, prevention, epidemiology and etiology. Original articles, research, reviews, mini reviews, cases, commentaries, short communications, letters, opinions are accepted for publication.

Submit manuscript to: editor.icst@oatext.com

 Breast cancer

Editor Affiliation:
Masakazu Toi, M.D. Ph.D,
Professor
Breast Surgery, Kyoto University
Japan

Submission date: December 10, 2019
Publication date: January 15, 2020

Description of the Special Issue: The special issue is interested in all areas of biology and medicine related to breast cancer, including basic biology, genetics, causes, diagnosis, treatment etc., with focus on latest advances in breast cancer therapy. All types of articles are accepted for publication.

Submit manuscript to: editor.icst@oatext.com

 Brain tumor

Editor Affiliation:
Damir Nizamutdinov
Associate Director of Neuro-Oncology Research
Department of Neurosurgery
Baylor Scott and White Health
Assistant Professor of Surgery
Texas A&M University
USA


Ekokobe Fonkem
Neuro-Oncologist
Baylor Scott & White Health
USA

Submission date: December 20, 2019
Publication date: January 16, 2020

Description of the Special Issue: The special issue accepts articles on all aspects related to the research in brain tumor and neuro oncology. Clinical and experimental results in tumor pathology, reviews, case reports on brain tumor, short communications, opinions, commentaries etc., are welcome for publication under this section.

Submit manuscript to: editor.icst@oatext.com

 Cancer Surgery

Editor Affiliation:
Johnson Miller Denise
Director
Hackensack Meridian Health
NJ, USA

Submission date: December 10, 2019
Publication date: January 15, 2020

The special issue focus on the surgical treatment of different cancer types like Breast Cancer, Lung Cancer, Kidney Cancer, Gastro intestinal cancer, gynaecological cancer, Thyroid Cancer, Prostate Cancer, neuro oncology, etc. All types of articles along with surgical images are suitable for publication.

Submit manuscript to: editor.icst@oatext.com

Most Viewed

Ataxia-telangiectasia

Adel Ekladious

Mini-Review-Integrative Cancer Science and Therapeutics (ICST)

June 13, 2021


A case of chylothorax due to diffuse large B-Cell lymphoma

Fusun Sahin

Case Report-Integrative Cancer Science and Therapeutics (ICST)

June 18, 2021


A case report of giant hepatic hemangioma spontaneous regression in adult, non-cirrhotic patient and literature review

Scarinci Andrea De Peppo Valerio Grazi Gian Luca

Case Report-Integrative Cancer Science and Therapeutics (ICST)

Nov 23, 2021


The effect of low doses of verapamil on the course of Kaposi's sarcoma

Gridina Nina Yakivna

Case Report-Integrative Cancer Science and Therapeutics (ICST)

Dec 10, 2021


Editorial comments to the articles published in Volume 8

Hiroshi Miyamoto

Case Report-Integrative Cancer Science and Therapeutics (ICST)

Dec 26, 2021


Submit your Next Article

  • Online submission
  • Highly indexed and abstracted
  • 7 years of successful publishing
  • Wider visibility though open access
  • Higher impact with wider visibility
  • Prompt review